Histone acetyltransferase MOZ acts as a co-activator of Nrf2–MafK and induces tumour marker gene expression during hepatocarcinogenesis

Por Ohta, Kumiko, Ohigashi, Megumi, Naganawa, Ayako, Ikeda, Hiromi, Sakai, Masaharu, Nishikawa, Jun-ichi, Imagawa, Masayoshi, Osada, Shigehiro, Nishihara, Tsutomu
Publicado em 2007

Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance

Por Hegazy, Ahmed M., Yamada, Daisuke, Kobayashi, Masahiko, Kohno, Susumu, Ueno, Masaya, Ali, Mohamed A. E., Ohta, Kumiko, Tadokoro, Yuko, Ino, Yasushi, Todo, Tomoki, Soga, Tomoyoshi, Takahashi, Chiaki, Hirao, Atsushi
Publicado no J Biol Chem (2016)

Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo

Por Niida, Hiroyuki, Murata, Kazuhiro, Shimada, Midori, Ogawa, Kumiko, Ohta, Kumiko, Suzuki, Kyoko, Fujigaki, Hidetsugu, Khaw, Aik Kia, Banerjee, Birendranath, Hande, M Prakash, Miyamoto, Tomomi, Miyoshi, Ichiro, Shirai, Tomoyuki, Motoyama, Noboru, Delhase, Mireille, Appella, Ettore, Nakanishi, Makoto
Publicado em 2010